Funding Research & Results

We are focused on solving the mystery of the causes of Parkinson's, developing new treatments for those who live with it and ending it forever.

Since our founding in 1957, PDF has supported more than $115 million in research with the goals of solving, treating and ending Parkinson's disease.

PDF's funding philosophy is to empower stakeholders — scientists, clinicians and other members of the scientific community — to identify novel questions about, and answers to, the puzzle of Parkinson’s. The research program is guided by PDF’s Scientific Advisory Committee, which is headed by Stanley Fahn, M.D., and comprises leading basic, clinical and translational scientists.

We fund research in four distinct ways. One of these is through Research Centers at major universities. Another is encouraging promising early-career investigators to devote their talents to the study of Parkinson's through mentored fellowships, training and career development opportunities. A third is funding independent investigators through our International Research Grants Program. And through the fourth, PDF is collaborating with other organizations on innovative projects.